Phase IB trial of high dose ascorbic acid + nab-paclitaxel + cisplatin + gemcitabine in patients with untreated metastatic pancreatic cancer.

Saved in:
Bibliographic Details
Title: Phase IB trial of high dose ascorbic acid + nab-paclitaxel + cisplatin + gemcitabine in patients with untreated metastatic pancreatic cancer.
Authors: Jameson GS; HonorHealth Research Institute, Scottsdale, AZ, USA. Electronic address: gjameson@HonorHealth.com., LeGrand SD; HonorHealth Research Institute, Scottsdale, AZ, USA., Gordon MS; HonorHealth Research Institute, Scottsdale, AZ, USA; Translational Genomics Research Institute (TGen), Part of City of Hope, Phoenix, AZ, USA., Roe DJ; The University of Arizona Cancer Center, Tucson, AZ, USA., Wertheim BC; The University of Arizona Cancer Center, Tucson, AZ, USA., Olszewski K; Ludwig Institute for Cancer Research, Princeton Branch, Princeton University, Princeton, NJ, USA., Rabinowitz J; Ludwig Institute for Cancer Research, Princeton Branch, Princeton University, Princeton, NJ, USA., Evans R; Salk Institute, La Jolla, CA, USA., Downes M; Salk Institute, La Jolla, CA, USA., Truitt M; Salk Institute, La Jolla, CA, USA., Korn R; Imaging Endpoints, Scottsdale, AZ, USA., Han H; Translational Genomics Research Institute (TGen), Part of City of Hope, Phoenix, AZ, USA., Miller RM; HonorHealth Research Institute, Scottsdale, AZ, USA., Barrett MT; Mayo Clinic, Scottsdale, AZ, USA., Propper D; Barts Cancer Institute, Queen Mary University of London, London, UK., Von Hoff DD; HonorHealth Research Institute, Scottsdale, AZ, USA; Translational Genomics Research Institute (TGen), Part of City of Hope, Phoenix, AZ, USA., Borazanci E; HonorHealth Research Institute, Scottsdale, AZ, USA.
Source: Redox biology [Redox Biol] 2025 Dec; Vol. 88, pp. 103895. Date of Electronic Publication: 2025 Oct 25.
Publication Type: Journal Article; Clinical Trial, Phase I; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: Elsevier, B.V Country of Publication: Netherlands NLM ID: 101605639 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-2317 (Electronic) Linking ISSN: 22132317 NLM ISO Abbreviation: Redox Biol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2213-2317
DOI:10.1016/j.redox.2025.103895